Abbott
Abbott (NYSE: ABT) is a global, broad-based healthcare company
devoted to the discovery, development, manufacture and marketing of
pharmaceuticals and medical products, including nutritionals,
devices and diagnostics. The company employs more than 68,000 people
and markets its products in more than 130 countries.
Abbott’s diagnostics businesses
Abbott is a global leader in in vitro diagnostics and offers a broad
range of innovative instrument systems and tests for hospitals,
reference labs, molecular labs, blood banks, physician offices and
clinics.
With more than 65,000 institutional customers in more than 100
countries, Abbott's diagnostic products offer customers automation,
convenience, bedside testing, cost effectiveness and flexibility.
Abbott has helped transform the practice of medical diagnosis from
an art to a science through the company's commitment to improving
patient care and lowering costs. Abbott’s history is filled with
examples of first-of-a-kind diagnostic products and significant
technological and research advancements.
Abbott Diabetes Care
Abbott Diabetes Care, based in Alameda, California, produces glucose
monitoring systems designed to help patients better manage their
diabetes. Abbott Diabetes Care is committed to developing products
to reduce the discomfort and inconvenience of blood glucose
monitoring and introducing systems that are easier to use, require
smaller blood samples and provide faster results.
Abbott Diabetes Care markets several glucose monitoring systems and
test strips in the United States for use in both home and hospital
settings; leading brands include FreeStyle® Lite, FreeStyle
Freedom™, FreeStyle Flash® and Precision Xtra™.
Website: www.abbott.com
|